Predicting Development of Hypertrophic Cardiomyopathy and Disease Outcomes in Cats

Jose Novo Matos1, Jessie Rose Payne2

  • 1Department of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge CB3 0ES, UK.

Insights

Echocardiography is key for diagnosing feline hypertrophic cardiomyopathy (HCM). Specific echocardiographic findings can predict HCM development and adverse outcomes, with left atrial dysfunction indicating a worse prognosis.

Area of Science:

  • Veterinary Cardiology
  • Diagnostic Imaging
  • Cardiovascular Disease in Cats

Background:

  • Hypertrophic cardiomyopathy (HCM) is a common cardiac disease in cats.
  • Echocardiography is the primary diagnostic tool for feline HCM.
  • Left atrial dysfunction is an early sign of HCM and linked to poor outcomes.

Purpose of the Study:

  • To highlight the role of echocardiography in diagnosing feline HCM.
  • To emphasize the predictive value of echocardiographic features for HCM development and adverse events.
  • To underscore the significance of left atrial dysfunction in HCM prognosis.

Main Methods:

  • Review of echocardiographic findings in feline hypertrophic cardiomyopathy.
  • Analysis of echocardiographic data to identify predictive features for disease progression and adverse events.
  • Evaluation of left atrial function as a prognostic indicator.

Main Results:

  • Echocardiography accurately diagnoses feline HCM.
  • Specific echocardiographic markers predict the risk of developing HCM.
  • Echocardiographic features identify cats with HCM at higher risk for cardiovascular events or death.
  • Left atrial dysfunction is an early abnormality and a predictor of worse outcomes.

Conclusions:

  • Echocardiography is essential for diagnosing and managing feline HCM.
  • Predictive echocardiographic features aid in risk stratification for cats with or at risk of HCM.
  • Left atrial dysfunction is a critical factor influencing the prognosis of feline hypertrophic cardiomyopathy.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
16
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
16
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
16
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
16